NRX Pharmaceuticals (NRXP) Return on Assets (2018 - 2026)
NRX Pharmaceuticals (NRXP) posted quarterly Return on Assets of 0.01% for Q1 2026, up 1.0% year-over-year from 0.01% in Q1 2025, and down 20.03% quarter-over-quarter from 0.01% in Q4 2025.
NRX Pharmaceuticals (NRXP) Return on Assets (2018 - 2026) Analysis & Trends
NRX Pharmaceuticals (NRXP) has reported Return on Assets for 9 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.08%, up 4.0% from the prior year.
- Return on Assets fell to 0.01% in Q1 2026 per NRXP's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q4 2025 and bottomed at 0.05% in Q2 2024.
- Historically, Return on Assets has averaged 0.03% across 5 years, with a median of 0.02% in 2022.
- Annual changes were most pronounced in 2022 — Return on Assets climbed 9 bps — and 2024, when it decreased 4 bps.
- NRX Pharmaceuticals' Return on Assets stood at 0.02% in 2022, then decreased by 17 bps to 0.02% in 2023, then slumped by 107 bps to 0.05% in 2024, then surged by 74 bps to 0.01% in 2025, then decreased by 20 bps to 0.01% in 2026.
- Business Quant data shows NRXP's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 0.00% |
| 10 | NRX Pharmaceuticals | 132.34 Mn | 105.64 Mn | 426,000.00 | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | -0.04% |
| Jun 30, 2024 | -0.05% |
| Mar 31, 2024 | -0.05% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | -0.04% |